Refine
Year of publication
Document Type
Way of publication
- Open Access (4)
Keywords
- chondrogenic differentiation (3)
- chondrogenic microtissues (2)
- dental pulp stem cells (2)
- microtissue (2)
- multiplexing (2)
- scaffold-free 3D culture (2)
- 2D/3D cultures (1)
- 3-D cell culture (1)
- 3D culture (1)
- ANCA (1)
- ANCA-associated vasculitis (1)
- Antinuclear antibodies (1)
- Articular cartilage (1)
- Autoantikörper (1)
- Autoimmune diagnostic (1)
- Autoimmune diagnostics (1)
- Automatic analysis (1)
- Automatisierung (1)
- BMP-7 (1)
- Biomaterialien - Strukturgeber und physiologischer Impulsgeber (1)
- Cartilage (1)
- Cartilage Repair Strategies (1)
- Cell Biology (1)
- Chondrocytes (1)
- CytoBead technology (1)
- Engineering cartilage-like microtissues without scaffolds (1)
- HEp-2 (1)
- HEp-2 cell (1)
- HEp-2 cells (1)
- Histology (1)
- Immunfluoreszenz (1)
- Immunofluorescence (1)
- Mesenchymale Stammzellen in der Regenerativen Therapie (1)
- Osteoclast (1)
- Pathology and Forensic Medicine (1)
- Redifferentiation of chondrocytes in a three-dimensional environment (1)
- Regenerative Zelltherapien für das Nervensystem (1)
- Regenerative Zelltherapien für die Haut (1)
- S100 protein as marker for chondrogenic development (1)
- Screening (1)
- TGF-β subtypes (1)
- WST-8, WST-1, XTT (1)
- Zellbasierte Verfahren zur Regeneration von Gelenkknorpel (1)
- adult stem cells (1)
- aggregation techniques (1)
- automated IIF methods (1)
- automated interpretation of ANCA IIF (1)
- cartilage (1)
- cartilage regeneration (1)
- cartilage-like microtissues (1)
- cell differentiation (1)
- cell therapy (1)
- chondrocyte (1)
- chondrocyte-derived cell line (1)
- confirmatory testing (1)
- cytochrome P450 enzyme (1)
- diagnostic (1)
- differentiation (1)
- differentiation of chondrocytes (1)
- discrimination and classification of cytoplasmic ANCA (C-ANCA) and perinuclear ANCA (P-ANCA) (1)
- extracellular matrix (1)
- fusion culture technique (1)
- immunohistochemistry (1)
- in vitro cartilage (1)
- in vitro cartilage defect (1)
- in vitro chondrogenesis (1)
- in vitro therapy culture system (1)
- in vitro therapy model (1)
- microbead immunoassays (1)
- microtissue generation (1)
- microtissues (1)
- mononuclear osteoclast (1)
- osteoclastic differentiation (1)
- pattern recognition algorithms (1)
- personalized diagnostic platform (1)
- personalized differentiation (1)
- platform for automated interpretation of cell-based IIF testing (1)
- responder/non-responder (1)
- scaffold-free (1)
- screening (1)
- serology (1)
- serum type (1)
- systemic autoimmune rheumatic disease (SARD) (1)
- therapy mimicry (1)
- tissue engineering (1)
- transplant integration (1)
- two-step fusion technique (1)
- vasculitis (1)
Institute
Primary human hepatocytes are in great demand during drug development and in hepatology. However, both scarcity of tissue supply and donor variability of primary cells create a need for the development of alternative hepatocyte systems. By using a lentivirus vector system to transfer coding sequences of Upcyte® proliferation genes, we generated non-transformed stable hepatocyte cultures from human liver tissue samples. Here, we show data on newly generated proliferation-competent HepaFH3 cells investigated as conventional two-dimensional monolayer and as organotypical three-dimensional (3D) spheroid culture. In monolayer culture, HepaFH3 cells show typical cobblestone-like hepatocyte morphology and anchorage-dependent growth for at least 20 passages. Immunofluorescence staining revealed that characteristic hepatocyte marker proteins cytokeratin 8, human serum albumin, and cytochrome P450 (CYP) 3A4 were expressed. Quantitative real-time PCR analyses showed that expression levels of analyzed phase I CYP enzymes were at similar levels compared to those of cultured primary human hepatocytes and considerably higher than in the liver carcinoma cell line HepG2. Additionally, transcripts for phase II liver enzymes and transporter proteins OATP-C, MRP2, Oct1, and BSEP were present in HepaFH3. The cells produced urea and converted model compounds such as testosterone, diclofenac, and 7-OH-coumarin into phases I and II metabolites. Interestingly, phases I and II enzymes were expressed at about the same levels in convenient monolayer cultures and complex 3D spheroids. In conclusion, HepaFH3 cells and related primary-like hepatocyte lines seem to be promising tools for in vitro research of liver functions and as test system in drug development and toxicology analysis.